The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical thawing system market was valued at US$ 178.2 Million in 2021.
We expect the global medical thawing system market to exhibit a CAGR of 7.8% during 2022-2027.
The high prevalence of several viral and bacterial infections, widespread adoption of organ
transplantation, and the increasing number of organ donors, represent some of the key factors
driving the global medical thawing system market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of medical
thawing systems for defrosting biological samples for biological research, safe storage, and
transportation of biopharma products pertaining to the coronavirus disease.
Based on the product type, the global medical thawing system market can be categorized into
manual and automated. Currently, manual medical thawing system holds the majority of the total
Based on the sample type, the global medical thawing system market has been segmented into
blood, embryo, ovum, and semen. Among these, blood sample type currently exhibits clear
dominance in the market.
Based on the end user, the global medical thawing system market can be bifurcated into blood
banks, hospitals, tissue banks, pharmaceutical and biotech companies, and others. Currently, blood
banks account for the largest market segment.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global medical thawing system market include Barkey GmbH & Co.
KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer
Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt
AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation), and Thermo Fisher
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at